Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Buschhorn

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Experimental Hematology & Oncology|April 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseStefanie Jilg, Richard T Hauch, Johanna Kauschinger, et al.
Blood Advances|December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosisVeronika Dill, Celina V Wagner, Eva C Keller, et al.
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Experimental Hematology & Oncology|April 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseStefanie Jilg, Richard T Hauch, Johanna Kauschinger, et al.
Blood Advances|December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosisVeronika Dill, Celina V Wagner, Eva C Keller, et al.
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 2